FDA OKs Merck drug that prevents infection post-stem cell transplant – Reuters
|
FDA OKs Merck drug that prevents infection post-stem cell transplant
Reuters (Reuters) – Merck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. Merck said the drug, which is expected to be … |
